Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents

NCT01341132 · clinicaltrials.gov ↗

UNKNOWN

Status

75

Enrollment

FED

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: MRI Scan of the Liver enhanced with Eovist

Sponsor

San Francisco Veterans Affairs Medical Center

Collaborators

[object Object]
[object Object]